Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, DAX 40, Dow, Bitcoin,
Share Talk Weekly Stock Market News Review, Sunday 20th November 2022
Overall, it was a decent week for London’s junior markets, with AIM100 up 0.39% to 4,034 though it lagged against the Footsie, which rose more than 0.8%.
RNS Hotlist with Zak Mir: QTZ, RGO, SEE, DOTD, INCE, CRTM, EST, CRCL, KMK, EVG, THX, PMG, GST, BEM & ENET via Vox Markets
Quetzal Capital (QTZ), which has conditionally agreed to acquire Tap Global Limited, a regulated, crypto-fiat exchange service provider, notes recent developments in cryptocurrency markets concerning FTX Group and questions around
Evgen Pharma PLC (AIM:EVG) Study started of new SFX-01 tablet formulation
First healthy volunteers dosed on schedule
Traders Cafe with Zak Mir: Bulletin Board Heroes, Tuesday 8th November 2022 via Vox Markets
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Dax, Dow, Bitcoin, Aston,
Traders Cafe with Zak Mir: Bulletin Board Heroes, Friday 21st October 2022 via Vox Markets
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, ARC Minerals, Baron Oil,
Trader’s Café with Zak Mir: A Week In Small Caps, Saturday 15th October 2022
Perhaps the best thing about the Government’s present woes as far as small caps are concerned is that we are already bumping along the bottom, or at least hope that
RNS Hotlist with Zak Mir: DVRG, IES, AGL, I3E, SLE, BION, KIST, SAR, CCZ, HSW, ANGS, EVG, EST & DKE
DeepVerge (DVRG) said it notes recent market speculation regarding forthcoming loan repayments and a potential equity fundraising.
Traders Cafe with Zak Mir: Bulletin Board Heroes, Tuesday 11th October 2022 via Vox Markets
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Dukemount Capital, eve Sleep,
RNS Hotlist with Zak Mir: EVG, HUI, MSMN, I3E, DKL, ZPHR, HE1, JAY, QUIZ, ORR & THR
Evgen Pharma (EVG), a clinical-stage drug development company, has licensed the global rights for lead asset SFX-01 in neurodevelopmental disorders and schizophrenia to Stalicla SA, a Swiss company specialising in
Evgen Pharma PLC (AIM:EVG) SFX-01 licensing deal for up to $160.5m
SFX-01 licensing deal for up to $160.5m in milestone payments expands lead asset into neurodevelopmental disorders